Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...

Merck trades at a low P/E with strong financials, Keytruda growth, and a solid 3.9% yield, while its pipeline offsets future risks. Read why MRK stock is a buy.

Serve your customers well, and the profits will follow, according to a new book. It rarely works the other way around, says ...

As UN treaty talks stall over plastic production cuts, global industry faces growing pressure to adapt supply chains and ...